Medico Intercontinental Intrinsic Value
Medico Intercontinental intrinsic value. Medico Intercontinental (MIL) median intrinsic value is ₹50.38 from 4 valuation models (range ₹32–₹63), vs current price ₹25.19 — +100.0% upside (Trading Below Calculated Value), margin of safety 50.0%. Read Medico Intercontinental dividend payments for the complete payout history and dividend yield track record.
MIL Valuation Methods Summary — DCF, Graham Number & P/E
Medico Intercontinental intrinsic value across 4 models vs current price ₹25.19 — upside/downside and value range per method. Compare with MIL fair value to assess whether the stock is under or overvalued.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹32.00 | ₹28.80 - ₹35.20 | +27.0% | Book Value/Share: ₹32.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹50.38 | ₹45.34 - ₹55.42 | +100.0% | Revenue/Share: ₹92.00, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹48.00 | ₹43.20 - ₹52.80 | +90.6% | EBITDA: ₹8.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹62.98 | ₹50.38 - ₹75.58 | +150.0% | CF Growth: 15.0%, Discount: 15% |
MIL Intrinsic Value vs Market Price — All Valuation Models
Medico Intercontinental fair value range ₹32–₹63 vs current market price ₹25.19 across 4 valuation models. For current market price and key ratios, visit MIL share price.
MIL Intrinsic Value Analysis — Undervalued or Overvalued?
Medico Intercontinental median intrinsic value ₹50.38, current price ₹25.19 — Trading Below Calculated Value by 100.0%, margin of safety 50.0%.
What is the intrinsic value of MIL?
Based on our comprehensive analysis using 4 different valuation methods, the estimated intrinsic value of Medico Intercontinental (MIL) is ₹50.38 (median value). With the current market price of ₹25.19, this represents a +100.0% variance from our estimated fair value.
The valuation range spans from ₹32.00 to ₹62.98, indicating ₹32.00 - ₹62.98.
Is MIL undervalued or overvalued?
Based on our multi-method analysis, Medico Intercontinental (MIL) appears to be trading below calculated value by approximately 100.0%.
MIL Financial Health — Key Ratios vs Industry Benchmarks
Medico Intercontinental financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.30 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | -25.0% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | 7.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.79x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
MIL Cash Flow Quality — Operating & Free Cash Flow
Medico Intercontinental operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹17 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-6 Cr | ₹-9 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹6 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |
| March 2023 | ₹-10 Cr | ₹-13 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹4 Cr | ₹4 Cr | Positive Free Cash Flow | 8/10 |